Overview Financials News + Filings Key Docs Transactions Holdings Ownership
|
UBS Group AG
> VERV
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Verve Therapeutics, Inc. | VERV | 88,074 | -2,761 | 1,651,388,000 | 341,547,000 | $18,750.01 |
| 03/31/2023 | Verve Therapeutics, Inc. | VERV | 90,835 | -152,939 | 1,309,841,000 | -3,407,186,000 | $14,420.00 |
| 12/31/2022 | Verve Therapeutics, Inc. | VERV | 243,774 | 210,071 | 4,717,027,000 | 4,715,870,000 | $19,350.00 |
| 09/30/2022 | Verve Therapeutics, Inc. | VERV | 33,703 | 33,553 | 1,157,000 | 1,155,000 | $34.33 |
| 06/30/2022 | Verve Therapeutics, Inc. | VERV | 150 | -106,101 | 2,000 | -2,422,000 | $13.33 |
| 03/31/2022 | Verve Therapeutics, Inc. | VERV | 106,251 | 81,921 | 2,424,000 | 1,527,000 | $22.81 |
| 12/31/2021 | Verve Therapeutics, Inc. | VERV | 24,330 | 21,030 | 897,000 | 742,000 | $36.87 |
| 09/30/2021 | Verve Therapeutics, Inc. | VERV | 3,300 | 1,769 | 155,000 | 63,000 | $46.97 |
| 06/30/2021 | Verve Therapeutics, Inc. | VERV | 1,531 | 1,531 | 92,000 | 92,000 | $60.09 |
| << Prev Next >> |
|